(NASDAQ: SSKN) Strata Skin Sciences's forecast annual revenue growth rate of 6.43% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.15%.
Strata Skin Sciences's revenue in 2025 is $30,980,000.On average, 4 Wall Street analysts forecast SSKN's revenue for 2025 to be $195,311,561, with the lowest SSKN revenue forecast at $176,469,324, and the highest SSKN revenue forecast at $213,035,040. On average, 4 Wall Street analysts forecast SSKN's revenue for 2026 to be $214,259,785, with the lowest SSKN revenue forecast at $193,439,114, and the highest SSKN revenue forecast at $233,867,488.
In 2027, SSKN is forecast to generate $209,048,729 in revenue, with the lowest revenue forecast at $200,852,356 and the highest revenue forecast at $215,196,009.